Study on katuki and sita churna for urdhvaga amlapitta efficacy.
Journal name: Ayushdhara
Original article title: A placebo controlled double blind comparative clinical study to evaluate the efficacy of katuki and sita churna in urdhvaga amlapitta
AYUSHDHARA is an international peer-reviewed journal. It focuses on research in Ayurveda, Yoga, Unani, Siddha, Homeopathy, Allopathy, and Pharmaceutical Sciences.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Bhanupriya Damba*
Final Year PG Scholar, Dept. of Kaya Chikitsa, S.V.M.Ayurvedic Medical College, Ilkal, Karnataka
P.V Joshi
Professor & HOD, Dept. of Kaya Chikitsa, S.V.M.Ayurvedic Medical College, Ilkal, Karnataka
Venkatesh. P
Lecturer, Dept. of Kaya Chikitsa, S.V.M.Ayurvedic Medical College, Ilkal, Karnataka
Ayushdhara:
(A peer-reviewed, bi-monthly open-access journal)
Full text available for: A placebo controlled double blind comparative clinical study to evaluate the efficacy of katuki and sita churna in urdhvaga amlapitta
Year: 2019
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Introduction
Urdhvaga Amlapitta is a pervasive condition affecting the gastrointestinal system, primarily due to irregular dietary habits and stressful lifestyles. It poses a significant treatment challenge because of its recurrent nature, largely attributed to faulty dietary practices. This clinical study aimed to evaluate the effectiveness of herbal remedies—Katuki and Sita Churna capsules—against a placebo in managing Urdhvaga Amlapitta. The study enrolled 30 patients who were randomly assigned to receive either the herbal treatment or the placebo over a 30-day period. The results indicated varying degrees of efficacy, highlighting the need for herbal interventions in addressing this common ailment.
Efficacy of Herbal Interventions
The study demonstrated that patients receiving Katuki and Sita capsules showed notable improvements in several symptoms associated with Urdhvaga Amlapitta, including Avipaka (improper digestion), Tikta/Amla Udgara (bitter/sour belching), and Hrit/Kanta Daha (burning sensation in the heart/throat). Statistical analysis revealed highly significant results in parameters such as Avipaka and Hrit/Kanta Daha, underscoring the therapeutic potential of these herbal formulations in reducing the severity of symptoms associated with this condition. The findings suggest that the combination of Katuki and Sita produces beneficial therapeutic effects, potentially due to their bioactive properties.
Placebo Effect Consideration
Interestingly, the placebo group also demonstrated some degree of improvement, albeit moderate or mild in severity. Certain symptoms like Tikta/Amla Udgara and Utklesha (nausea) showed significant changes post-treatment in this group, indicating that psychological factors could influence perception of improvement in patients. This highlights the importance of considering placebo effects in clinical trials, particularly in conditions where symptoms can fluctuate and may be influenced by cognitive or emotional states. The study emphasized that while the herbal interventions were effective, patient perception and placebo response need to be acknowledged as contributing factors.
Conclusion
In conclusion, the research indicated that Katuki and Sita capsules have a significant impact on alleviating symptoms of Urdhvaga Amlapitta, reinforcing the therapeutic viability of Ayurvedic treatments. While patients receiving the placebo also reported improvements, suggesting a notable placebo effect, the herbal capsules exhibited more substantial benefits. The findings advocate for the continued exploration of plant-based treatments in managing gastrointestinal conditions, offering hope for patients seeking alternatives to conventional medicine. No adverse effects were reported during the study, reinforcing the safety profile of the herbal interventions utilized.
FAQ section (important questions/answers):
What is the objective of the clinical study on Katuki and Sita?
The study aimed to evaluate the efficacy of Katuki and Sita capsules in managing Urdhvaga Amlapitta, a common digestive disorder, through a placebo-controlled, double-blind clinical trial.
What were the main findings of the treatment with Katuki and Sita?
Results indicated that Katuki and Sita capsules provided moderate improvement in symptoms of Urdhvaga Amlapitta, while the placebo group showed only mild improvement, suggesting the effectiveness of the herbal treatment.
Were there any side effects reported during the study?
No adverse effects were reported during the treatment or the follow-up period, indicating that Katuki and Sita capsules were well tolerated by the patients involved in the study.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Study on katuki and sita churna for urdhvaga amlapitta efficacy.”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Katuki:
Katuki is an herbal drug used in the treatment of Urdhvaga Amlapitta. Known for its Katu Tiktarasa, Katuvipaka, SheetaVeerya, Ruksha, and Laghuguna properties, Katuki serves as a Pittarechaka (Pitta purifier) and is used for its Kaphahara and Deepana Pachanakarma actions.
2) Sita (Shita):
Sita, also referred to as Sheetophala, is an herbal ingredient used alongside Katuki in this study. It has Madhurarasa, Madhuravipaka, and Sheetaveerya properties, which help in relieving Vata and Pitta doshas, making it useful in the management of Urdhvaga Amlapitta.
3) Food:
Improper and irregular food habits are identified as one of the major contributing factors to Urdhvaga Amlapitta, a disease affecting Annavaha srotas (GIT). The study emphasizes the importance of diet in either aggravating or managing this condition.
4) Amlapitta (Amla-pitta):
Amlapitta, or acid reflux syndrome, is characterized by symptoms including heartburn, hyperacidity, and gastritis, among others. The study evaluates Katuki and Sita Churna capsules for their efficacy in managing this condition.
5) Daha:
Hrut/Kanta Daha refers to the burning sensation experienced in the chest and throat, a common symptom of Urdhvaga Amlapitta. The study finds a slightly significant improvement in this symptom with the use of Katuki and Sita capsules.
6) Drug:
The clinical trial involves comparing the effects of herbal drugs, namely Katuki and Sita Churna capsules, against a placebo, to determine their efficacy in treating Urdhvaga Amlapitta.
7) Aruci:
Aruchi refers to the loss of appetite or taste, a minor symptom of Urdhvaga Amlapitta. This study assesses changes in Aruchi among patients treated with Katuki and Sita capsules compared to a placebo group.
8) Amla:
Amla refers to sourness, which is a common symptom in conditions like Urdhvaga Amlapitta. Consumption of Amla food items can exacerbate the condition, thereby spotlighting its relevance in dietary considerations.
9) Disease:
Urdhvaga Amlapitta is described as a challenging disease to treat due to its recurrence and dietary implications. This research aims to offer an effective Ayurvedic approach to manage this disease.
10) Avipaka:
Avipaka, or indigestion, is one of the major symptoms of Urdhvaga Amlapitta. The study measures the improvement in digestion times following the treatment with Katuki and Sita capsules.
11) Tikta:
Tikta (bitter) is a quality associated with Katuki, one of the herbal drugs used in this study. The bitterness of Tikta helps in the management of Urdhvaga Amlapitta by balancing Pitta and promoting digestive health.
12) Klama:
Klama is a symptom of Urdhvaga Amlapitta characterized by fatigue and tiredness. The study evaluates how the treatment with Katuki and Sita capsules impacts the levels of Klama in patients.
13) Utklesha (Utklesa):
Utklesha refers to nausea and is a minor symptom of Urdhvaga Amlapitta. The study records the frequency and severity of Utklesha before and after treatment to assess the efficacy of Katuki and Sita capsules.
14) Udgara:
Tikta/Amla Udgara is the bitter and sour belching experienced by patients with Urdhvaga Amlapitta. One of the parameters in the study measures the reduction of Udgara symptoms after Ayurvedic treatment.
15) Kantha (Kamtha):
Kantha refers to the throat area where symptoms like Daha (burning sensation) can occur in Urdhvaga Amlapitta. The study monitors changes in throat-related symptoms with the treatment.
16) Kanta (Kamta):
[see source text or glossary: Kanta]
17) Kaya:
Kaya, meaning body, is part of Kaya Chikitsa or body treatments in Ayurveda. The study conducted falls under this department, focusing on internal medicine practices.
18) Hrid (Hrt, Hrit, Hrd):
Hrit refers to the heart region where patients may experience a burning sensation (Hrut Daha) as a symptom of Urdhvaga Amlapitta. The study measures the reduction in Hrit Daha as one of its parameters.
19) Ayurveda (Ayus-veda):
Ayurveda is the ancient Indian science of life and health. This study uses Ayurvedic principles and treatments to address the disease Urdhvaga Amlapitta with herbal formulations like Katuki and Sita Churna.
20) Vomiting:
Vomiting or Chardi is a minor symptom seen in Urdhvaga Amlapitta. The study tracks the frequency and severity of vomiting episodes to evaluate the effectiveness of the herbal treatment.
21) Sira (Shira):
Shira refers to the head, where patients might experience headaches (Shirashoola) as a symptom of Urdhvaga Amlapitta. The study documents the impact of the treatment on Shirashoola.
22) Madhurarasa (Madhura-rasa):
Madhurarasa refers to the sweet taste and is a property of Sita. This quality is beneficial in counteracting the symptoms of Urdhvaga Amlapitta, making Sita a relevant component in the treatment.
23) Karnataka:
Karnataka is a state in India where the study was conducted at S.V.M. Ayurvedic Medical College in Ilkal. The geographical context provides insight into the demographics and lifestyle factors of the patient population.
24) Ruksha (Ruksa):
Ruksha, meaning dry, is one of the properties of Katuki. This quality, along with others like Laghu (light) and Sheeta (cold), makes Katuki effective in treating Pitta-related conditions like Urdhvaga Amlapitta.
25) Srotas (Shrotas):
Srotas refers to bodily channels or systems, specifically Annavaha srotas (digestive tract) in the context of Urdhvaga Amlapitta. Proper functioning of these channels is crucial for managing the disease.
26) Chardi:
Chardi, or vomiting, is used as a symptom assessment metric in the study to gauge the efficacy of Katuki and Sita capsules in treating Urdhvaga Amlapitta. Reduction in Chardi is one of the signs of treatment success.
27) Powder:
Katuki and Sita are both processed into fine powder (churna) before being encapsulated for use in the clinical study. The quality and preparation of this powder are crucial for the effectiveness of the treatment.
28) Pitta:
Pitta, one of the three doshas in Ayurveda, plays a significant role in the pathology of Urdhvaga Amlapitta. The herbal treatments aim to balance Pitta to alleviate symptoms such as hyperacidity and heartburn.
29) Joshi (Josi):
Dr. P.V. Joshi is the Professor and HOD at the Dept. of Kaya Chikitsa, S.V.M. Ayurvedic Medical College in Ilkal, who guided the research study on the efficacy of Katuki and Sita Churna in managing Urdhvaga Amlapitta.
30) India:
India is the country where the study was conducted. Ayurvedic treatments such as those used in this research are deeply rooted in Indian traditional medicine practices.
31) Ulcer:
Gastric and duodenal ulcers are among the exclusion criteria for the study participants, ensuring that the subjects only had Urdhvaga Amlapitta without other complicating gastro-intestinal conditions.
32) Katu:
Katu (pungent) is one of the tastes associated with Katuki. This quality helps in improving digestion and balancing the Pitta dosha, making it suitable for treating Urdhvaga Amlapitta.
33) Pain:
Pain, particularly in the digestive tract or head (Shirashoola), is a symptom assessed in the study. Managing pain is a key aspect of treating Urdhvaga Amlapitta effectively.
34) Tridoshahara (Tridosahara, Tridosha-hara):
[see source text or glossary: Tridosha-hara]
35) Vatapittahara (Vatapitta-hara):
Vatapittahara means 'alleviating Vata and Pitta doshas.' Sita has Vatapittahara properties, making it useful in the treatment of Urdhvaga Amlapitta where balancing these doshas is crucial.
36) Manasikabhava (Manasika-bhava):
Manasikabhava refers to mental states or emotions. This study recognizes that psychological factors play a significant role in the manifestation and management of Urdhvaga Amlapitta.
37) Laghubhojana (Laghu-bhojana):
Laghubhojana, meaning light diet, is one of the dietary recommendations in Ayurveda for managing Urdhvaga Amlapitta. Light meals are easier to digest and help in reducing symptoms.
38) Amlagandha (Amla-gandha):
Amla-gandha refers to the sour smell, often a symptom of Urdhvaga Amlapitta due to the regurgitation of acidic contents. This study assesses the reduction of such symptoms with herbal treatment.
39) Perception:
Perception plays a role in the placebo effect observed in the study, where patients receiving placebo capsules showed mild improvement, emphasizing the psychological component in the treatment of Urdhvaga Amlapitta.
40) Discussion:
The discussion section of the study elaborates on the results, providing interpretation on the efficacy and significance of using Katuki and Sita for Urdhvaga Amlapitta, with comparisons to the placebo group.
41) Tridosha (Tridosa, Tri-dosha):
[see source text or glossary: Tridosha]
42) Shodhana (Sodhana):
Shodhana refers to cleansing practices in Ayurveda, which are part of the recommended treatment plan for Urdhvaga Amlapitta. Detoxifying the body helps in alleviating symptoms and preventing recurrence.
43) Medicine:
[see source text or glossary: Medicine]
44) Pregnant:
Pregnant women are excluded from the study on Urdhvaga Amlapitta, ensuring the safety and validity of the clinical trial as the treatments were not tested for effects on pregnancy.
45) Langhana (Lamghana):
Langhana refers to therapeutic fasting or taking light food aimed at reducing aggravated doshas. This approach is part of the Ayurvedic management for Urdhvaga Amlapitta.
46) Madhura:
[see source text or glossary: Madhura]
47) Gaurava:
[see source text or glossary: Gaurava]
48) Vidahi:
[see source text or glossary: Vidahi]
49) Jarana:
[see source text or glossary: Jarana]
50) Gandha (Gamdha):
[see source text or glossary: Gandha]
51) Vipaka:
[see source text or glossary: Vipaka]
52) Nidana:
[see source text or glossary: Nidana]
53) Gorava (Go-rava):
[see source text or glossary: Gorava]
54) Nausea:
[see source text or glossary: Nausea]
55) Nature:
[see source text or glossary: Nature]
56) Karma (Karman):
[see source text or glossary: Karma]
57) Laghu:
[see source text or glossary: Laghu]
58) Ushna (Usna):
[see source text or glossary: Ushna]
59) Ayus (Ayush):
[see source text or glossary: Ayush]
60) Hara:
[see source text or glossary: Hara]
61) Guna:
[see source text or glossary: Guna]
62) Kala:
[see source text or glossary: Kala]
63) Diet:
[see source text or glossary: Diet]
Other Science Concepts:
Discover the significance of concepts within the article: ‘Study on katuki and sita churna for urdhvaga amlapitta efficacy.’. Further sources in the context of Science might help you critically compare this page with similair documents:
Pitta, Amlapitta, Statistical analysis, Inclusion criteria, Exclusion criteria, Comparative clinical study, Trial Drug, Subjective parameter, Objective parameter, Overall improvement, Faulty lifestyle, Herbal drug, Urdhvaga Amlapitta.